We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.

Close

CMFT prepares for arrival of state-of-the-art laboratory equipment

Work is underway to prepare CMFT's Clinical Sciences Centre for the arrival of state-of-the-art equipment that will place the laboratory at the forefront of technological developments in pathology.

In order for Roche Diagnostics, our commercial partner, to install the new platforms, considerable changes to the estates are required, which will enable us to streamline our processes across Blood Sciences.

The building works, which commenced February, will see the ground floor of the laboratory areas opened up to increase the available space, facilitating a more automated approach to the delivery of our services with the introduction of the Roche p612 and 8100 pre-analytics.

Roche has already installed several new pieces of equipment which are already making a difference to service delivery, such as:

  • Roche Cobas 8000 system in Virology Serology alongside the Roche Cobas 4800 and Cobas 6800/8800 systems currently in place in Molecular Virology
  • Sysmex coagulation and Sysmex XN line for Haematology
  • Grifols Erytra for Blood Transfusion
  • Bioplex 2200 for Immunology, alongside Phadia 250/1000 and Werfen DS2

This is a phased process with future placements planned, including:

  • Werfen Quantalyser 240, Binding Site Optilite immunoassay and Beckman Coulter Aquios and Navios for Immunology testing
  • Beckman Coulter Access II supporting Haematology testing

The changes are being phased over eleven stages due to the extent of the works planned. Ever mindful that we will maintain our current quality service and continue supporting the CMFT campus, referring hospitals and GP practices amidst the changes.

With the equipment installed blood sciences will benefit from 'tracked solutions', which will require minimal manual intervention, facilitate easier reflex testing, support sharing of samples hence reducing blood draw and improving patient outcomes.

The final stage of the process is due for completion September 2018.